Silvia Maria Stoicescu 1, Ramona Ciocoiu 2, D. Orăşeanu 3
1 Neonatology Professor, Chief of Department of Neonatology – “Polizu” Maternity, Institute for Mother and Child Care “Al. Rusescu”, “Carol Davila” University of Medicine and Pharmacy, Bucharest
2 Resident neonatology physician IOMC “Polizu”
3 Pediatrics Professor, Clinical Emergency Hospital for Childern “Grigore Alexandrescu”, “Carol Davila” University of Medicine and Pharmacy, Bucharest
Abstract
Introduction. Viral bronchiolitis is the most frequent pathology of the respiratory tract in infants and toddlers (under 2 years of age), the respiratory syncytial virus being one of the most commonly incriminated agents. Th e incidence of respiratory syncytial virus bronchiolitis reported by the Clinical Emergency Hospital for Children “Grigore Alexandrescu” during the past years is increasing. Materials and methods. retrospective study over 2 years (2007 – 2008). In 2007, 9 Romanian Maternities started out in the program for prevention of the respiratory infection with respiratory syncytial virus with Palivizumab provided through donations. Results. 140 newborns were passively immunized, none of them presented respiratory syncytial virus infection. Conclusions. Th ere is need for the elaboration of an administering guide for Palivizumab and there is need for a national program which would include clear selection criteria, specifi c to the newborn population from our country, which could benefit from the prophylaxis of the respiratory syncytial virus.